Related Experiment Video

Updated: Mar 14, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Emerging data on androgen receptor splice variants in prostate cancer

Subing Cao1,2, Yang Zhan1,2, Yan Dong3,2

  • 1College of Life SciencesJilin University, Changchun, Jilin, China.

Endocrine-Related Cancer
|October 6, 2016
PubMed

Insights

Androgen receptor splice variants drive castration-resistant prostate cancer. Targeting these variants offers a promising therapeutic strategy for improving treatment outcomes in advanced prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Androgen receptor splice variants (AR-Vs) are truncated forms of the androgen receptor.
  • AR-Vs play a crucial role in castration-resistant prostate cancer (CRPC) progression.
  • AR-Vs are implicated in therapeutic resistance to current prostate cancer treatments.

Purpose of the Study:

  • To review the generation mechanisms of AR-Vs.
  • To elucidate the clinical significance and action mechanisms of AR-Vs.
  • To discuss the therapeutic implications of targeting AR-Vs in CRPC.

Main Methods:

  • Literature review of recent studies on AR-Vs.
  • Analysis of data on AR-V generation and function.
  • Synthesis of information on clinical relevance and therapeutic strategies.

Main Results:

  • AR-Vs are generated through alternative splicing and lack the ligand-binding domain.
  • AR-Vs are key mediators of resistance in CRPC.
  • Understanding AR-V generation and action is critical for developing targeted therapies.

Conclusions:

  • Targeting AR-Vs is essential for effective CRPC treatment.
  • Further research into AR-V mechanisms will guide novel therapeutic approaches.
  • AR-V targeted therapies hold promise for overcoming treatment resistance in prostate cancer.
Keywords:
androgen receptorcofactorsdimerizationprostate cancersplice variant

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.4K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.5K

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K